|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
DE69535243T2
(de)
|
1994-07-13 |
2007-05-10 |
Chugai Seiyaku K.K. |
Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
|
|
DK1069185T3
(da)
|
1998-04-03 |
2011-06-27 |
Chugai Pharmaceutical Co Ltd |
Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof
|
|
DK1071700T3
(da)
|
1998-04-20 |
2010-06-07 |
Glycart Biotechnology Ag |
Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
CA2704600C
(en)
|
1999-04-09 |
2016-10-25 |
Kyowa Kirin Co., Ltd. |
A method for producing antibodies with increased adcc activity
|
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
|
DE10359795A1
(de)
|
2003-12-19 |
2005-07-21 |
Bayer Technology Services Gmbh |
Strangverdampfervorrichtung
|
|
BRPI0911926A2
(pt)
|
2008-08-05 |
2020-08-18 |
Toray Industries, Inc |
composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo.
|
|
EP2711018A1
(en)
|
2009-06-22 |
2014-03-26 |
MedImmune, LLC |
Engineered Fc regions for site-specific conjugation
|
|
EP2480671B8
(en)
|
2009-09-22 |
2015-10-28 |
ProBioGen AG |
Process for producing molecules containing specialized glycan structures
|
|
HUE040012T2
(hu)
|
2010-02-04 |
2019-02-28 |
Toray Industries |
Gyógyászati ágens rák kezelésére és/vagy megelõzésére
|
|
DK2532366T3
(da)
|
2010-02-04 |
2017-01-02 |
Toray Industries |
Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
|
|
DK2532680T3
(da)
|
2010-02-04 |
2015-07-20 |
Toray Industries |
Medicinsk sammensætning til behandling og/eller forebyggelse af cancer
|
|
CA2788545C
(en)
|
2010-02-04 |
2019-03-26 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
|
US9115200B2
(en)
*
|
2010-02-04 |
2015-08-25 |
Toray Industries, Inc. |
Pharmaceutical composition for treating cancer using a monoclonal antibody having immunological reactivity with CAPRIN-1
|
|
RU2603742C2
(ru)
|
2010-02-04 |
2016-11-27 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и/или профилактики рака
|
|
JP2013528357A
(ja)
|
2010-03-29 |
2013-07-11 |
ザイムワークス，インコーポレイテッド |
強化又は抑制されたエフェクター機能を有する抗体
|
|
PL2740793T3
(pl)
|
2011-08-04 |
2018-04-30 |
Toray Industries, Inc. |
Kompozycja leku do leczenia i/lub zapobiegania nowotworowi
|
|
US9181348B2
(en)
|
2011-08-04 |
2015-11-10 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
|
PT2740489T
(pt)
|
2011-08-04 |
2017-01-10 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou a prevenção do cancro pancreático
|
|
PT2740796T
(pt)
|
2011-08-04 |
2017-07-26 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou profilaxia de cancro
|
|
RU2595400C2
(ru)
|
2011-08-04 |
2016-08-27 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
|
|
EP2740794B1
(en)
|
2011-08-04 |
2018-04-04 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
|
WO2013125654A1
(ja)
|
2012-02-21 |
2013-08-29 |
東レ株式会社 |
癌の治療及び／又は予防用医薬組成物
|
|
ES2739612T3
(es)
|
2012-02-21 |
2020-02-03 |
Toray Industries |
Composición farmacéutica para el tratamiento de cáncer
|
|
US9260513B2
(en)
*
|
2012-02-21 |
2016-02-16 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
BR112014021103A2
(pt)
|
2012-02-21 |
2019-10-15 |
Toray Industries, Inc |
Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
|
|
WO2013147176A1
(ja)
|
2012-03-30 |
2013-10-03 |
東レ株式会社 |
胆嚢癌の治療及び／又は予防用医薬組成物
|
|
JP6107654B2
(ja)
|
2012-03-30 |
2017-04-05 |
東レ株式会社 |
肝臓癌の治療及び／又は予防用医薬組成物
|
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
AU2014303375B2
(en)
|
2013-08-09 |
2019-07-04 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
CA3061874A1
(en)
*
|
2017-06-22 |
2018-12-27 |
Novartis Ag |
Il-1beta binding antibodies for use in treating cancer
|
|
AU2019242520B2
(en)
*
|
2018-03-30 |
2026-02-26 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
JP7103097B2
(ja)
|
2018-09-13 |
2022-07-20 |
トヨタ自動車株式会社 |
燃料電池車両
|